Category: Accuray Inc.Syndicate content

Cancer: Accuray lands 510(k) clearance for next-gen CyberKnife

November 2, 2012 by MassDevice staff

The FDA grants 510(k) clearance to Accuray's CyberKnife M6 radiosurgery device for treating cancerous tumors.

Accuray

Accuray (NSDQ:ARAY) won 510(k) clearance from the FDA for the latest iteration of its CyberKnife radiosurgery device.

Chief commercial officer Kelly Londy told MassDevice.com that the Sunnyvale, Calif.-based medical device company is launching the product immediately.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Accuray details new CEO appointment | Personnel Moves

October 22, 2012 by MassDevice staff

Radiotherapy devices maker Accuray details new CEO Joshua Levine's appointment.

fired/hired

 Accuray details new CEO's position

Accuray CEO Euan Thomson quits company, replaced by Joshua Levine

October 12, 2012 by MassDevice staff

Euan Thomson abruptly resigns from Sunnyvale, Calif.-based medical device maker Accuray, will be replaced by former Mentor Corp., Immucor CEO.

Accuray logo

Medical device company Accuray (NSDQ:ARAY) said CEO Euan Thomson has left the company and will be replaced by Joshua Levine, the former CEO of Mentor Corp. and Immucor.

Cancer: Accuray's losses widen as it prepares for "major technology launch"

September 10, 2012 by MassDevice staff

Medical device maker Accuray reports that its losses jumped 170% during fiscal 2012, cautioning that Q1 results will be dramatically lower as it ramps up for a new product launch this fall.

Accuray logo

Medical device company Accuray (NSDQ:ARAY) said it's completed a "year of transition" as it looks to the release of 2 new products in October, which it says will help "change the dynamic" of the radiosurgery market.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Medtronic: Defibrillator market is stabilizing | Wall Street Beat

September 6, 2012 by MassDevice staff

The prolonged slump in the U.S. defibrillator market appears to have stabilized, according to medical device company Medtronic.

MassDevice.com Wall Street Beat

Medtronic (NYSE:MDT) said the slump that's hit its bread-and-butter cardiac rhythm management division where it hurts appears to have stabilized, despite the 5% sales slide during its fiscal 1st quarter.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Battle in Silicon Valley: Device makers trade barbs in the fight to gain share in robot assisted procedures

August 16, 2012 by Arezu Sarvestani

The best way to beat Intuitive Surgical out of the corner it has on the prostate cancer treatment market is by amping up the aggression, radiosurgery veteran and Varian chief medical officer John Adler tells MassDevice.com.

boxing gloves

Radiosurgery innovator and medtech veteran John Adler is ready for a fight.

The outspoken inventor of Accuray's (NSDQ:ARAY) CyberKnife system, as well as the company's founder and former CEO, Adler is an evangelist for radiosurgery and its potential in a variety of applications.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Study: Robot assisted prostate surgery may lower rates of incontinence, impotence

August 9, 2012 by MassDevice staff

Prostate surgery with robotic assistance may cause less impotence and incontinence than laparoscopic surgery, according to a small Italian study.

da Vinci robot assisted surgery

Robot assisted prostate surgery may lower rates of urinary incontinence and post-surgery impotence when compared with minimally invasive laparoscopy, according to a small Italian study.

The study only comprised 120 patients who were randomized to receive a prostatectomy with either an unnamed robot assistant or with tiny tools manipulated by hand. All surgeries were performed by a single surgeon.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp